Canopy Growth

(NYSE: CGC)
Healthcare  |  Drug Manufacturers—Specialty & Generic
17.86 -0.55 -2.99%
Stock Price | Feb. 28, 2020, 10:21 a.m.
11 Followers
Bid: 17.85
Ask: 17.89
Prev. Close: 18.41
52 Week Low: 13.81
52 Week High: 52.74
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 02/28/20

7 Comments
14 hours ago

Premium Cannabis Stocks Review - AM Edition 02/27/20

57 Comments
23 hours ago

Premium Instead of a Pre-Market Video 02/25/20

25 Comments
3 days ago

Premium Bouncing Along the Bottom

14 Comments
4 days ago

Premium Cannabis Stocks Review - Weekend Edition 02/24/20

15 Comments
6 days ago

Premium Cannabis Stocks Review - AM Edition 02/20/20

13 Comments
1 week ago

Premium Toking Tuesday Chat - 02/18/20

19 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 02/18/20

5 Comments
1 week ago

Premium Breaking Down Canopy Growth’s Growth in Fiscal Q3

58 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 02/18/20

8 Comments
1 week ago